BY LAURAN NEERGAARD ASSOCIATED PRESS A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca. The U.S. recommended that states pause giving the J&J vaccine on Tuesday while authorities examine six reports of the unusual clots, […]
The post What’s known about J&J’s vaccine and rare clots appeared first on Florida Courier.
